Max Healthcare Institute Limited (MAXHEALTH) — Financial Results | 21 May 2025(2 announcements)

· NSE 🔴 High Importance ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Max Healthcare Institute reported consolidated revenue of ₹87.22 crores for Q4 FY2025, up 32% YoY, with net profit rising 69.9% to ₹22.72 crores. The company finalized the acquisition of Jaypee Healthcare Limited, finalized merger schemes with ALPS Hospital and Crosslay Remedies, and proposed a dividend of INR 1.50 per share for FY2024-25.

2 Financial Results 🔴 High Importance ✨ Positive 📄 PDF

Max Healthcare Institute reported a 69.9% YoY revenue increase to ₹87.22 crores for Q4FY25, driven by strong hospital services growth, while net profit rose 32% to ₹125.6 crores on improved operational efficiency and cost management.

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day